Oct. 8, 2021: State Advocacy Update

| 2 Min Read

DEA issues public health advisory about counterfeit pills

After seizing more than 9.5 million counterfeit pills in 2021, many of them containing deadly amounts of illegally manufactured fentanyl, the U.S. Drug Enforcement Administration (DEA) has issued a public health advisory about record numbers of counterfeit pills being made to look like prescription medication.

Haven't subscribed?

Stay current on the latest on the issues impacting physicians, patients and the health care environment with the AMA’s Advocacy Update newsletter.

According to the DEA, the counterfeits “are made to look like prescription opioids such as oxycodone (Oxycontin®, Percocet®), hydrocodone (Vicodin®) and alprazolam (Xanax®); or stimulants like amphetamines (Adderall®).”

The DEA also emphasized that, “this alert does not apply to legitimate pharmaceutical medications prescribed by medical professionals and dispensed by pharmacists.”

The AMA supports educating people about the risks of taking drugs that have not been prescribed to them, increasing access to treatment for substance use disorders and multiple harm reduction options to help save lives from a drug-related overdose, including:

Additional resources on the drug overdose epidemic are available at End the Overdose Epidemic and by contacting the AMA Advocacy Resource Center.

FEATURED STORIES

Attentive surgeon engaged in operation

NPs, PAs cite high satisfaction with physician-led care

| 5 Min Read
Blurry figures walking in a hallway

Physician recruiters most often seek these specialties

| 6 Min Read
Cheerful patient in medical exam room

Better communication boosts patient experience, physician well-being

| 8 Min Read
Columns of the U.S. Supreme Court at top of steps

8 wins for doctors, patients in latest federal budget deal

| 4 Min Read